Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Comment by bigmack1on Oct 06, 2010 2:22pm

285 Views

Post# 17536160

RE: RE: BioInvestor forum presentation worth seein

Looks like we should finally see some movement here, I like the odds and will hold no matter what the outcome.. Its emotional for me do to a very difficult death in the family. My father died from PSP complications close to four years ago and I will hold these shares for better or worse!
Best of luck traders.
Dave

Bullboard Posts

Canopy Growth nears adjusted EBITDA profitability in Q2 2025